List of Lumos Pharma patents | 8 results

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 11485705 Salts and prodrugs of 1-methyl-d-tryptophan	Patent 11485705 was granted and assigned to Lumos Pharma on November, 2022 by the United States Patent and Trademark Office.	Lumos Pharma	Lumos Pharma	United States Patent and Trademark Office	11485705	November 1, 2022
‌ US Patent 10898472 Detecting and treating growth hormone deficiency	Patent 10898472 was granted and assigned to Lumos Pharma on January, 2021 by the United States Patent and Trademark Office.	Lumos Pharma	Lumos Pharma	United States Patent and Trademark Office	10898472	January 26, 2021
‌ US Patent 10105352 Detecting and treating growth hormone deficiency	Patent 10105352 was granted and assigned to Lumos Pharma on October, 2018 by the United States Patent and Trademark Office.		Lumos Pharma	United States Patent and Trademark Office	10105352	October 23, 2018
‌ US Patent 11234969 Detecting and treating growth hormone deficiency	Patent 11234969 was granted and assigned to Lumos Pharma on February, 2022 by the United States Patent and Trademark Office.	Lumos Pharma	Lumos Pharma	United States Patent and Trademark Office	11234969	February 1, 2022
‌ US Patent 10377721 Synthesis of cyclocreatine and analogs thereof	Patent 10377721 was granted and assigned to Lumos Pharma on August, 2019 by the United States Patent and Trademark Office.	Lumos Pharma	Lumos Pharma	United States Patent and Trademark Office	10377721	August 13, 2019
‌ US Patent 10081605 Synthesis of cyclocreatine and analogs thereof	Patent 10081605 was granted and assigned to Lumos Pharma on September, 2018 by the United States Patent and Trademark Office.	Lumos Pharma	Lumos Pharma	United States Patent and Trademark Office	10081605	September 25, 2018
‌ US Patent 10493062 Synthesis of cyclocreatine and analogs thereof	Patent 10493062 was granted and assigned to Lumos Pharma on December, 2019 by the United States Patent and Trademark Office.	Lumos Pharma	Lumos Pharma	United States Patent and Trademark Office	10493062	December 3, 2019
‌ US Patent 11969416 Compactable oral formulations of ibutamoren	Patent 11969416 was granted and assigned to Lumos Pharma on April, 2024 by the United States Patent and Trademark Office.	Lumos Pharma	Lumos Pharma	United States Patent and Trademark Office	11969416	April 30, 2024